Cheltenham General Hospital is an NHS district general hospital in Cheltenham, Gloucestershire, run by Gloucestershire Hospitals NHS Foundation Trust. It provides general hospital services including Accident and Emergency.
BACKGROUND AND AIMS:Tip control (TC) is a core endoscopic skill, yet objective and practical in vivo assessment tools are lacking. We developed and gathered validity evidence for a scoring method using snare-tip soft coagulation (STSC) of the post-EMR defect margin as a standardized task. METHODS:A prospective, single-center observational study of consecutive patients undergoing EMR for large (≥20 mm) nonpedunculated colorectal polyps was conducted. Live or video observers used a web tool to classify STSC applications as correct ("on-margin") or incorrect. Outcomes were accuracy, speed (correct hits/min), z-standardized composite score (z_accuracy + z_speed = performance index), and rater subjective impression. Group differences (experts >500 EMRs vs trainees <50 EMRs) were estimated with generalized linear mixed-effects models, with random intercepts for endoscopist, observer, and procedure. Interrater reliability (intraclass coefficient [2,k]) was calculated. RESULTS:Sixty-eight procedures performed by 14 endoscopists were scored by 19 observers (170 ratings; median 2 per procedure; IQR, 1-3). Experts (n = 3) outperformed trainees (n = 11) for accuracy (adjusted mean, 90.0% vs 81.2%; adjusted mean difference [AMD], +8.9 percentage points [95% CI, 4.6-12.9]; P < .001) and speed (13.3 correct hits/min [95% CI, 11.0-15.6] vs 9.7 [95% CI, 8.0-11.4]; AMD, +3.6 correct hits/min [95% CI, 0.9-6.3]; P = .01). The performance index for experts was significantly higher than for trainees (AMD, +1.4 [95% CI, 0.7-2.2]; P < .001). Overall impression scores also favored experts (AMD, +1.0 points on 0-10 scale [95% CI, 0.5-1.6]; P < .001). ICC(2,k) for overall impression and accuracy was excellent (ICC[2,k] = 0.98 and 0.97, respectively). Convergent validity was demonstrated by significant associations between overall impression and both accuracy (β = 0.8 per 10 percentage points [95% CI, 0.7-1.0]; P < .001) and speed (β= 0.7 per 10 hits/min [95% CI, 0.4-1.0]; P < .001). CONCLUSIONS:A simple, in vivo, procedure-level score captured during routine STSC provided an objective measure of endoscopic tip TC, separating experts from trainees.
INTRODUCTION:Pancreatic cancer (PC) treatment in the UK is coordinated via regional referral networks, but formal neoadjuvant chemotherapy (NAC) pathways for borderline resectable and locally advanced PC (BR/LAPC) are rare. This cohort study assessed intranetwork variation in access to diagnostics, time to treatment and patient outcomes following NAC for BR/LAPC in our network. METHODS:All patients with BR/LAPC referred from regional network hospitals between 2017 and 2021 were reviewed. Data were collected on time from first diagnostic computed tomography scan to endoscopy, commencement of NAC, NAC regimens administered and patient outcomes. RESULTS:In the 155 patients who commenced NAC, there were significant differences in median time to biliary drainage and endoscopic ultrasound between referral hospitals. Time from decision to treat to first administration of NAC was long (median 64 days). There were significant differences in the proportion of patients commenced on mFOLFIRINOX (0-100%, p<0.001) and the proportion completing NAC (0-100%, p=0.012). The likelihood of proceeding to surgical resection was similar between centres. CONCLUSIONS:There is significant intranetwork variation in access to interventional endoscopy and choice of NAC regimen. Centralised tracking of patients receiving NAC, development of locally agreed treatment protocols and an update to national guidelines are needed to standardise NAC pathways for BR/LAPC.
We demonstrate that broadband coherent anti-Stokes Raman scattering (BCARS) on hematoxylin and eosin (H&E)-stained tissue generates a hybrid vibrational-electronic spectroscopic contrast arising from coupled Raman-active vibrations and chromatin-hematoxylin electronic resonances. This hybrid response, inaccessible to conventional spontaneous Raman or infrared microscopy due to fluorescence and substrate interference, transforms routine histology slides into sources of quantitative molecular information. The resulting spectra encode both Raman-active vibrations and resonance-modulated four-wave-mixing contributions arising from hemalum-chromatin interactions, thereby linking histological color contrast to quantitative, machine-readable spectral features. In breast tissue microarrays, we show (i) pixel-wise wavenumber-shift mapping that resolves subnuclear domains and highlights necrosis-associated nuclear shrinkage; (ii) phase-retrieved Raman-like spectra that separate hemalum-associated resonant features from nonpigmented contributions attributable to processing reagents; and (iii) nucleus-level discrimination of ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), and invasive lobular carcinoma (ILC) using a PCA-LDA workflow. This study is a feasibility demonstration rather than a clinical validation, but establishes electronically enhanced BCARS on routine H&E slides as a route to unlock archival repositories for molecular phenotyping and AI-enabled histopathology.
ObjectiveThe purpose of this study was to identify patients within the Gloucestershire Diabetic Eye Screening Programme (DESP) over the age of 80 years at low risk of developing treatable diabetic retinopathy (DR).SettingThe county of Gloucestershire, UK.MethodsThis study evaluated treatment outcomes between August 2005 and December 2025 for patients who were negative for retinopathy and maculopathy at the last screen before their 80th birthday (group A) and had one negative screen post 80 years (group A1) or two negative screens post 80 (group A2), and patients without a prior history of DESP attendance before the age of 80 but with one negative screen post 80 (group B).ResultsIn group A1, 4713 patients had 26,446 subsequent screening episodes; 280 were referred, with 8 requiring intravitreal treatment (IVT) for diabetic macular oedema (DMO), 4 requiring laser therapy, and 1 requiring both. In group A2, 2264 patients had 13,602 subsequent screening episodes; 3 were referred but only 1 required IVT for DMO. In group B, 3867 patients had 17,447 subsequent screening episodes; 275 were referred but only 1 required IVT for DMO.ConclusionsPolicy makers should consider whether it is in the best interest of elderly patients with a very low risk of developing treatable DR (groups A2 and B) to continue to invite them for screening for the rest of their life as they become increasingly frail.